CDKN2A and neoplasm: While 5-aza-dC is reported to reactivate a tumor suppressor p16INK4A gene [41], no tumor suppressor candidate gene was found among the commonly reactivated genes in PJ-34, 5-aza-dC, and TSA treatments in the either the HCT116 or RKO cell lines.